Minutes of the first special meeting held
at 4045 Côte-Vertu Blvd., Saint-Laurent, via conference call, on Friday, June 22, 2001, at 2:00 PM (translation)
1. Opening of the meeting
2. Adoption of agenda
3. Presentation and adoption of Héma-Québec's 2000-2001 financial statements - Auditor General of Québec presentation
The Chair of the Audit Committee mentioned that the Committee has reviewed Héma-Québec's financial statements which were issued without reservation by the Auditor General for the year ended March 31, 2001 to the Audit Committee on June 21. Members of the Audit Committee unanimously recommended that the Board of Directors adopt the financial statements as submitted.
The Committee also met with Auditor General of Québec representatives following their audit of the financial statements for the year ended March 31, 2001. The Audit Committee Chair pointed out that many improvements, compared to last year, were noted as most minor deficiencies detected by an internal audit have, for the most part, been corrected. The Auditor General representatives stated that they were satisfied with the financial statements presented by management. No comments, other than those in the financial statements, will be issued by the Auditor General in its report to be submitted to the National Assembly on June 30, 2001.
Further to the audit, the Auditor General made certain comments concerning the reconciliation of accounts between Héma-Québec and the Canadian Blood Services. The hiring of a new Director, Stable Products, should improve the situation.
Moreover, the Finance and Administration Senior Director's team and the Auditor General's team have come to an agreement regarding plasma cost allocation. However, the Senior Director, Finance and Administration has been asked to find out the practices in use at other organizations that have the same mission as Héma-Québec in order to validate our costing method.
The members of the Board of Directors were apprised of the importance of discussing the budget for labile and stable products for 2001-2002. This item will be discussed at the next Board of Directors meeting on June 27, 2001.
The members of the Board of Directors stated that they were satisfied with the presentation and congratulated the Senior Director, Finance and Administration, as well as every member of his team, for their preparation of the financial statements.
It was proposed, duly seconded and unanimously resolved that the Héma-Québec financial statements for the year ended March 31, 2001, a copy of which is appended hereto, be adopted.
It was proposed, duly seconded and unanimously resolved that Claude Pichette and Cheryl Campbell Steer be designated signatories of the Héma-Québec financial statements for the year ended March 31, 2001.
5. Next meeting
Dr. Francine Décary